Husband to wife kidney transplantation in five multiparous women: Sensitization or tolerance after pregnancy?;Trasplante renal de esposo a esposa en cinco mujeres multíparas. ¿Efecto sensibilizante o efecto "tolerogénico" de la gestación?

Revista de Investigacion Clinica

Volumn 56, Issue 4, 2004, Pages 427-436

  Ortiz Arroyo, Víctor M ^a   Granados, Julio ^a   Uribe Uribe, Norma ^a   de Leo, Claudia ^a   Castelán, Natalia ^a   González, Norma ^a   López, Mayra ^a   Alberú, Josefina ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Acute humoral rejection; Blood transfusions; Graft loss; Husband to wife kidney transplantation; Pregnancies

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; IMMUNOGLOBULIN ANTIBODY; METHYLPREDNISOLONE; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; B LYMPHOCYTE; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CLINICAL ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; MULTIPARA; NEPHRECTOMY; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PREGNANCY; SPOUSE; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

ADULT; FAMILY; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PARITY; PREGNANCY; SPOUSES;

EID: 7444252264     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet 1999; 353: 1083-91.
2. Wyner LM, Novick AC, Streem SB, Hodge EE. Improved success of living unrelated renal transplantation with cyclosporine immunosuppression. J Urol 1993; 149: 706-8.
3. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333-6.
4. Sanfilippo F, Vaughn WK, Bollinger RR, Spees EK. Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. Transplantation 1982; 34: 360-6.
5. Iwaki Y, Terasaki PI. Sensitization effect. Clin Transpl 1986; 257-65.
6. Halloran PF. The clinical importance of alloantibody-mediated rejection. Am J Transplant 2003; 3: 639-40.
7. Bohmig GA, Regele H, Saemann MD, Exner M, Druml W, Kovarik J, et al. Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft. Am J Kidney Dis 2000; 35: 667-73.
8. Feucht HE. Complement C4d in graft capillaries- the missing link in the recognition of humoral alloreactivity. Am J Transplant 2003; 3: 646-52.
9. Crespo M, Pascual M, Tolkoff-Rubin N, Mauiyyedi S, Collins AB, Fitzpatrick D, et al. I. Acute humoral rejection in renal allograft recipients: Incidence, serology and clinical characteristics. Transplantation 2001; 71: 652-8.
10. Toyoda M, Pao A, Petrosian A, Jordan SC. Pooled human gammaglobulin modulates surface molecule expression and induce apoptosis in human B cells. Am J Transplant 2003; 3: 156-66.
11. Jordan S, Cunningham-Rundles C, McEwan R. Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications. Am J Transplant 2003; 3: 653-64.
12. Rodey GE. HLA Beyond Tears. Introduction to human histocompatibility. USA: De Novo, Inc; 2000: 69.
13. Alexander JW, Light JA, Donaldson LA, Delmonico FL, Diethelm AG, Wilkinson A, et al. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. Transplantation 1999; 68: 1117-24.
14. Matthews JB, Ramos E, Bluestone JA. Clinical trials of transplant tolerance: Slow but steady progress. Am J Transplant 2003; 3: 794-803.
15. Jiang S, Lechler RI. Regulatory T cells in the control of transplantation tolerance and autoimmunity. Am J Transplant 2003; 3: 516-24.
16. Balwin WM, Halloran PF. Clinical syndromes associates with antibody in allografts. In: Racusen LC, Solez K, Burdick JF (eds). Kidney transplant rejection. New York, NY: Dekker; 1998, p. 127-47.
17. Feucht HE, Opelz G. The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int 1996; 50: 1464-75.
18. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-22.
19. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-23.
20. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, et al. Antibody -mediated rejection criteria- an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-14.
21. Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS. The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation 1990; 49: 85-91.
22. Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF. Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema. Transplantation 1996; 61: 1586-92.
23. Gebel HM, Bray RA, Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 2003; 3: 1488-500.